These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9624416)
1. Expression of mdm2 and p53 in epithelial neoplasms of the colorectum. Hao XP; Günther T; Roessner A; Price AB; Talbot IC Mol Pathol; 1998 Feb; 51(1):26-9. PubMed ID: 9624416 [TBL] [Abstract][Full Text] [Related]
2. MDM2/p53 protein expression in the development of colorectal adenocarcinoma. Abdel-Fattah G; Yoffe B; Krishnan B; Khaoustov V; Itani K J Gastrointest Surg; 2000; 4(1):109-14. PubMed ID: 10631371 [TBL] [Abstract][Full Text] [Related]
3. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum. Jackson PA; Green MA; Pouli A; Hubbard R; Marks CG; Cook MG J Clin Pathol; 1995 Dec; 48(12):1098-101. PubMed ID: 8567994 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232 [TBL] [Abstract][Full Text] [Related]
5. Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas. Broll R; Stark A; Windhövel U; Best R; Strik MW; Schimmelpenning H; Schwandner O; Kujath P; Bruch HP; Duchrow M Eur J Cancer; 1999 Jul; 35(7):1083-8. PubMed ID: 10533452 [TBL] [Abstract][Full Text] [Related]
6. Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence. Hao XP; Ilyas M; Talbot IC Pathobiology; 1997; 65(3):140-5. PubMed ID: 9309780 [TBL] [Abstract][Full Text] [Related]
7. mdm2-p53 Interaction: lack of correlation with the response to 5-fluorouracil in advanced colorectal cancer. Paradiso A; Ranieri G; Simone G; Silvestris N; Costa A; De Lena M; Leone A; Vallejo C; Lacava J Oncology; 2002; 62(3):278-85. PubMed ID: 12065876 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas. Valassiadou KE; Stefanaki K; Tzardi M; Datseris G; Georgoulias V; Melissas J; Tsiftsis DD; Delides G; Kanavaros P Anticancer Res; 1997; 17(4A):2571-6. PubMed ID: 9252682 [TBL] [Abstract][Full Text] [Related]
9. P53-protein accumulation and MDM2-protein overexpression in gastric carcinomas. No apparent correlation with survival. Kasper HU; Schneider-Stock R; Mellin W; Günther T; Roessner A Pathol Res Pract; 1999; 195(12):815-20. PubMed ID: 10631716 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma. Kawasaki Y; Monden T; Morimoto H; Murotani M; Miyoshi Y; Kobayashi T; Shimano T; Mori T Am J Clin Pathol; 1992 Feb; 97(2):244-9. PubMed ID: 1546693 [TBL] [Abstract][Full Text] [Related]
11. Proliferation and apoptosis in proliferative lesions of the colon and rectum. Kikuchi Y; Dinjens WN; Bosman FT Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892 [TBL] [Abstract][Full Text] [Related]
12. Bcl-2 expression in colorectal tumours. Correlation with p53, mdm-2, Rb proteins and proliferation indices. Goussia AC; Ioachim E; Agnantis NJ; Mahera M; Tsianos EV Histol Histopathol; 2000 Jul; 15(3):667-72. PubMed ID: 10963109 [TBL] [Abstract][Full Text] [Related]
13. No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis. Blok P; Craanen ME; Dekker W; Offerhaus GJ; Tytgat GN J Pathol; 1998 Sep; 186(1):36-40. PubMed ID: 9875138 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas. Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: Correlations with clinicopathologic features. Horie S; Maeta H; Endo K; Ueta T; Takashima K; Terada T Pathol Int; 2001 Jan; 51(1):11-5. PubMed ID: 11148457 [TBL] [Abstract][Full Text] [Related]
16. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases. Emanuels AG; Koudstaal J; Burger MP; Hollema H Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975 [TBL] [Abstract][Full Text] [Related]
17. Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation. Ropponen KM; Kellokoski JK; Pirinen RT; Moisio KI; Eskelinen MJ; Alhava EM; Kosma VM J Clin Pathol; 2001 Jul; 54(7):533-8. PubMed ID: 11429425 [TBL] [Abstract][Full Text] [Related]
18. Mdm2 and the p53 pathway in human pituitary adenomas. Suliman M; Royds J; Cullen D; Timperley W; Powell T; Battersby R; Jones TH Clin Endocrinol (Oxf); 2001 Mar; 54(3):317-25. PubMed ID: 11298083 [TBL] [Abstract][Full Text] [Related]
19. Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epithelia. Xi HQ; Zhang KC; Li JY; Cui JX; Zhao P; Chen L World J Surg Oncol; 2017 Apr; 15(1):90. PubMed ID: 28449687 [TBL] [Abstract][Full Text] [Related]
20. MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma. Ambros RA; Sheehan CE; Kallakury BV; Ross JS; Malfetano J; Paunovich E; Figge J Mod Pathol; 1996 Dec; 9(12):1165-9. PubMed ID: 8972476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]